Genmab A/S (GNMSF)
320.00
+4.00
(+1.27%)
USD |
OTCM |
Dec 11, 10:42
Genmab Total Liabilities (Quarterly): 1.27B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk A/S | 53.90B |
| Ascendis Pharma A/S | 1.561B |
| Evaxion AS | 14.90M |
| IO Biotech, Inc. | 39.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.021B |
| Shareholders Equity (Quarterly) | 5.751B |
| Debt to Equity Ratio | 0.0247 |
| Current Ratio | 6.034 |
| Net Debt Paydown Yield | 0.00% |